AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease

    NEXT STORY
    Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis
    PREV STORY
    OSE Immunotherapeutics Announces Results of 2019 Annual Shareholder Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer

    author_avatar
    NASDAQ Market News

    Helix BioPharma Corp. and Moffitt Cancer Center to Present at the AACR Annual Meeting 2019 in Atlanta

    author_avatar
    NASDAQ Market News

    Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting

    author_avatar
    NASDAQ Market News